Search Within

Andreas Rimner

  1. "Isabel Preeshagul"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
  3. Editorial (1)
Groups
  1. Department of Medicine (10)
  2. Radiation Oncology, Department of (10)
  3. Solid Tumor Oncology Division (10)
  4. Thoracic Oncology (10)
  5. Weinberg Fellows (9)
  6. Biostatistics Service (6)

More Groups

People
  1. Daniel Gomez (10)
  2. Isabel Preeshagul (10)
  3. Daphna Gelblum (9)
  4. Narek Shaverdian (8)
  5. Abraham Wu (7)
  6. Annemarie Shepherd (7)

More People

Years
  1. 2024 (3)
  2. 2022 (4)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Radiotherapy and Oncology (2)
  3. Annals of Translational Medicine (1)
  4. Journal of Thoracic Oncology (1)
  5. Lancet (1)
  6. Nature Medicine (1)
Publishers
  1. Elsevier Inc. (7)
  2. AME Publishing Company (1)
  3. Elsevier Science, Inc. (1)
  4. Nature Publishing Group (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Planned interim analysis of a phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Rimner, A.; Fitzgerald, K.; Iqbal, A. N.; Shepherd, A. F.; Gomez, D. R.; Shin, J. Y.; Gelblum, D. Y.; Hajj, C.; Albrecht, F.; Kotecha, R. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
    Journal Article

    Thor, M.; Shepherd, A. F.; Preeshagul, I.; Offin, M.; Gelblum, D. Y.; Wu, A. J.; Apte, A.; Simone, C. B. 2nd; Hellmann, M. D.; Rimner, A.; more...
    Radiotherapy and Oncology (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Editorial

    Shepherd, A. F.; Preeshagul, I. R.; Shaverdian, N.; Wu, A. J.; Gelblum, D. Y.; Gomez, D. R.; Rimner, A.; Simone, C. B. 2nd
    Annals of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Real-world evaluation of consolidative durvalumab in locally advanced non-small-cell lung cancer treated with definitive chemoradiation
    Meeting Abstract

    Shaverdian, N.; Zhang, Z.; Lobaugh, S.; Deasy, J. O.; Offin, M.; Preeshagul, I.; Hellmann, M. D.; Chaft, J.; Shepherd, A. F.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save